Atlas Trials

Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT00094835 · COMPLETED

Trial details

NCT number
NCT00094835
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Lung CancerNon-Small Cell Lung Cancer
Start date
2005-01-01
Primary completion
2007-03-01
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.